Minor Protease Inhibitor Mutations at Baseline Do Not Increase the Risk for a Virological Failure in HIV-1 Subtype B Infected Patients

• Alexandra U. Scherrer ,

  * E-mail: alexandra.scherrer@usz.ch

  Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland

  ⨯
• Bruno Ledergerber,

  Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland

  ⨯
• Viktor von Wyl,

  Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland

  ⨯
• Jürg Böni,

  Affiliation Institute of Medical Virology, Swiss National Center for Retroviruses, University of Zürich, Zürich, Switzerland

  ⨯
• Sabine Yerly,

  Affiliation Laboratory of Virology, Geneva University Hospitals, Geneva, Switzerland

  ⨯
• Thomas Klimkait,

  Affiliation Institute for Medical Microbiology, University of Basel, Basel, Switzerland

  ⨯
• Cristina Cellerai,

  Affiliation Division of Immunology and Allergy, University Hospital Lausanne, Lausanne, Switzerland

  ⨯
• Hansjakob Furrer,

  Affiliation Division of Infectious Diseases, University Hospital Berne, University of Berne, Berne, Switzerland

  ⨯
• Alexandra Calmy,

  Affiliation Division of Infectious Diseases, University Hospitals Geneva, Geneva, Switzerland

  ⨯
• Matthias Cavassini,

  Affiliation Infectious Diseases Service, University Hospital Lausanne, Lausanne, Switzerland

  ⨯
• Luigia Elzi,

  Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland

  ⨯
• Pietro L. Vernazza,

  Affiliation Division of Infectious Diseases, Cantonal Hospital St. Gallen, St. Gallen, Switzerland

  ⨯
• Enos Bernasconi,

  Affiliation Division of Infectious Diseases, Regional Hospital Lugano, Lugano, Switzerland

  ⨯
• Huldrych F. Günthard,

  Affiliation Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland

  ⨯
• and the Swiss HIV Cohort Study (SHCS)

  ¶Membership of the Swiss HIV Cohort Study is provided in the Acknowledgments.

  ⨯